Genomewide DNA hypomethylation is a consistent finding in human tumors, but the importance of this change for human tumorigenesis remains an open question. We have previously reported that mice carrying a hypomorphic allele for the maintenance DNA methyltransferase (Dnmt1 chip/À ) are hypomethylated and develop thymic lymphomas, demonstrating that genomewide DNA hypomethylation can induce tumors. Hypomethylated cells exhibit inherent chromosomal instability, which is revealed in the lymphomas as a consistent trisomy of chromosome 15. We now report another aspect of the molecular basis for tumor development upon DNA hypomethylation. Seven out of 16 hypomethylationinduced lymphomas were found to contain an intracisternal A particle (IAP) somatic insertion in the middle of the Notch1 genomic locus, leading to generation of an oncogenic form of Notch1 in the tumors. This finding suggests that the molecular basis for hypomethylationinduced tumors in this model involves chromosomal instability events accompanied by activation of endogenous retroviral elements. Our findings validate the proposed role of DNA methylation in suppression of transposable elements in mammalian cells and demonstrate the importance of DNA methylation for normal cell function as well as the potential consequences of spontaneously occurring or chemically induced DNA hypomethylation.
Genomewide DNA hypomethylation is a consistent finding in human tumors, but the importance of this change for human tumorigenesis remains an open question. We have previously reported that mice carrying a hypomorphic allele for the maintenance DNA methyltransferase (Dnmt1 chip/À ) are hypomethylated and develop thymic lymphomas, demonstrating that genomewide DNA hypomethylation can induce tumors. Hypomethylated cells exhibit inherent chromosomal instability, which is revealed in the lymphomas as a consistent trisomy of chromosome 15. We now report another aspect of the molecular basis for tumor development upon DNA hypomethylation. Seven out of 16 hypomethylationinduced lymphomas were found to contain an intracisternal A particle (IAP) somatic insertion in the middle of the Notch1 genomic locus, leading to generation of an oncogenic form of Notch1 in the tumors. This finding suggests that the molecular basis for hypomethylationinduced tumors in this model involves chromosomal instability events accompanied by activation of endogenous retroviral elements. Our findings validate the proposed role of DNA methylation in suppression of transposable elements in mammalian cells and demonstrate the importance of DNA methylation for normal cell function as well as the potential consequences of spontaneously occurring or chemically induced DNA hypomethylation. Oncogene (2008) 27, 404-408; doi:10.1038/sj.onc.1210631; published online 9 July 2007 Keywords: DNA hypomethylation; transposable elements; Notch1; T-cell lymphoma Proper methylation of genomic DNA is essential for normal development and for survival of somatic cells (Li et al., 1992; Jackson-Grusby et al., 2001) . Human tumors display abnormal methylation patterns including genomewide hypomethylation and site-specific hypermethylation (Ehrlich, 2002; Jones and Baylin, 2002) . To understand the effects of genomewide hypomethylation and the significance of this change in cancer, we developed a hypomorphic allele for the maintenance of DNA methyltransferase (Dnmt1 Chip ) . Compound heterozygous mice carrying the hypomorphic allele over a null allele (Dnmt1 chip/À ) are viable, but are hypomethylated and develop thymic lymphomas with a characteristic trisomy of chromosome 15 .
To understand further the molecular basis of hypomethylation-induced tumors, we compared the gene expression profile in thymic lymphomas to that of wildtype (wt) thymus. Interestingly, among the most significantly overexpressed genes were c-myc and Notch1. Upregulation of these genes was verified by northern blot analysis (Figure 1 ). Both genes have been shown to act as oncogenes and to cooperate in human and mouse T-cell lymphomas (Ellisen et al., 1991; Girard et al., 1996; Zweidler-McKay and Pear, 2004) . Oncogenic activity of Myc is frequently the result of increase in gene copy number (amplification) and elevated expression level (reviewed in Nesbit et al., 1999) . Using Southern blot analysis, we did not observe any drastic amplification of c-myc (data not shown). However, in mice, c-myc resides on chromosome 15. Thus, the consistent trisomy observed in hypomethylation-induced tumors may account for the oncogenic contribution of c-myc. Overexpression of Notch1 was also confirmed by northern blot. Intriguingly, in addition to the normal full-length Notch1 transcript, the hypomethylation-induced tumors displayed additional shorter transcripts of variable size (Figure 1 ). Oncogenic activation of Notch1 often involves retroviral insertions or chromosomal translocations, which introduce an ectopic promoter to the region, and drive the expression of a truncated protein product, comprising the intracellular portion of the protein (Ellisen et al., 1991; Girard et al., 1996; Zweidler-McKay and Pear, 2004) . We therefore searched the Notch1 region for evidence of genomic rearrangements. Southern blot analysis revealed genetic changes in several tumors ( Figure 2 ). Further Southern blot analysis mapped the changes to introns between exons D and F of Notch1. We applied inverse PCR (iPCR; Suzuki et al., 2002) to clone and sequence the mutated site. The sequence revealed that the genetic change was the result of transposition of an endogenous retroviral-like element known as intracisternal A particle (IAP) into the Notch1 locus. Further analysis confirmed this observation in 7/ 16 tumors ( Figure 2c ). All insertions were in the forward direction and included a 4 bp target site duplication characteristic for retroviral integration mechanism. Tail DNA from the same mice carrying the tumors did not contain the transposition, indicating that this was a somatic event. Importantly, all integrations occurred between exon D (which includes the extracellular protease cleavage site of the Notch receptor) and exon F, which codes the transmembranal region of the protein (Figure 2c ).
To determine whether the IAP insertion contributes an ectopic promoter that directs expression of new transcripts coding for a truncated Notch1 product, we first searched for hybrid transcripts containing IAP sequences followed by Notch coding exons. Using reverse transcription-PCR analysis with a forward primer from the IAP LTR region and a reverse primer from Notch1 exon F, we observed PCR products of variable size in the tumors that contained the IAP transposition (Figure 3a) . Sequencing the PCR products confirmed the nature of the hybrid transcripts, with chip/À tumors) compared to WT thymus. Twenty micrograms total RNA were loaded. The full-length Notch1 transcripts (two bands in the 10 kb range) are found at low levels in wt thymus and elevated levels in the tumors. In addition, short transcripts are detected in the tumors, primarily with the 3 0 probe corresponding to the intracellular portion of Notch1. Probe A (from 5 0 of transcript) and probe K (covering most of the intracellular (3 0 ) portion of the transcript) are described in (Hoemann et al., 2000) . (b) Quantification by densitometry of blots from panel (a). Signals were quantified using Image Gauge V3.45 and normalized to GAPdH levels. White columns, WT samples; Black columns, dnmt1/ chipÀ tumors. GAPdH, glyceraldehyde-3-phosphate dehydrogenase . Integration sites were determined by sequencing inverse PCR (iPCR) products (Suzuki et al., 2002) generated from genomic DNA re-ligated after KpnI digestion and using primers K3: 5 0 -AACAGCAGGAGCTG GAGCACT-3 0 and K4: 5 0 -CAGTGTGTCCCTGGGTTCTCT AAC-3 0 . Additional integration sites were determined by sequencing PCR products generated using U-IAP-F primer: 5 0 -ATGAC TACTTGTGCTCTGCCTTCC-3 0 and NotchEr or NotchFr: 5 0 -GCCACGTACATGAGGTGCAG-3 0 primers. IAP, intracisternal A particle.
Transposition in hypomethylation induced tumors G Howard et al some transcripts originating from the 5 0 -LTR and others driven by 3 0 -LTR into the intronic region downstream of the insertion point and are then spliced into exons E or F of Notch1 (Figure 3b ). This situation highly resembles lymphomas in which Moloney virus (MOV) integrations into the same introns of Notch1 were shown to produce oncogenic, constitutively active, truncated Notch1 products (Ellisen et al., 1991; Girard et al., 1996; Zweidler-McKay and Pear, 2004) . We next used 5 0 -RACE (Ansari-Lari et al., 1996) to define the transcription start site of the hybrid products in a representative number of tumors. We identified several start sites with variation between the tumors, and possibly multiple start sites within a single tumor (Supplementary Figure  1) . Ectopic expression driven by IAP promoters has been reported in the past. Different transcription start sites were reported in these cases and transcripts were found to originate from multiple sites, sometime in both sense and antisense directions (Christy and Huang, 1988; Michaud et al., 1994; Rakyan et al., 2003; Druker et al., 2004) . Thus, the ectopic transcription start site may vary depending on the insertion site, the type of IAP, and possibly, the epigenetic status (for example, methylation pattern) of the inserted element. To support further the presence of an ectopic promoter, we exclude the possibility that the IAP-Notch1 hybrid transcripts are driven by the canonical Notch1 promoter, since we could find hybrid transcripts between IAP and downstream Notch1 exons, but not upstream exons (Supplementary Figure 2) .
Large-scale studies using retroviral insertional mutagenesis to induce T-cell lymphoma in mice identified 152 tumor-associated retroviral integration sites including Notch1 and other Notch pathway members (Suzuki et al., 2002) . To search for additional transposition events in hypomethylation-induced tumors, we expanded the Southern blot analysis to cover 35 kb of the Notch1 locus and to additional proto-oncogenes that are known to play a role in T-cell lymphomas including c-myc, Pim1 and Bmi1, but could not identify evidence of genomic rearrangement in these loci (summarized in Supplementary Table) . Considering the large number of possible integration sites, it is not possible to determine if tumors without IAP integration in Notch1 develop by a different mechanism or if transposon-mediated insertional mutagenesis occurred elsewhere in these tumors. However, elevated IAP expression was observed in all Dnmt1
Chip/À tumors (Figure 4 ), supporting the later possibility. IAP elements are found in about 1000 copies per haploid genome and are normally epigenetically silenced (Boeke and Stoye, 1997) . IAP transposition is documented in cultured cells (Kuff, 1990) or as germ line mutations in vivo (Michaud et al., 1994) . To the best of our knowledge, this is the first example of a cancercausing IAP transposition that occurred in vivo in somatic tissue. To determine whether the same IAP element was activated in all tumors or different elements were activated, we evaluated the size of the inserted element in different tumors using Southern blot analysis (data not shown). On the basis of their size, the IAP elements inserted into Notch1 in different tumors were not identical and could be divided into three size groups, suggesting that random activation of different IAP copies rather than activation of a single, specific IAP copy was responsible for the different events. This was further supported by sequence data obtained from the IAP-Notch1 hybrid transcripts: all cloned hybrids varied in their IAP portion suggesting that they originate from different IAP elements (Supplementary Figure 3) . IAP expression is suppressed by DNA methylation and was found to be significantly elevated in demethylated ES cells and embryos (Walsh et al., 1998) . Mice carrying the hypomorphic allele Dnmt1
Chip/À exhibit genomewide DNA hypomethylation in all tissues and throughout embryonic development ), yet we could not find any significant increase in IAP expression in a variety of tissues from the preleukemic Dnmt1
Chip/À mice or in MOV-induced lymphomas (Figure 4 ). Elevated IAP expression was detected only in the Dnmt1
Chip/À tumors (Figure 4 ). Although IAP transcripts of several sizes are observed in the tumors, it remains to be determined whether IAP expression in the tumors is originating primarily from the newly inserted copy/ies or whether upregulation of IAPs precedes transposition and is triggered by further demethylation or by additional events.
DNA methylation imposes a significant burden on cells, but is essential for mammalian development and for cell survival (Li et al., 1992; Jaenisch, 1997; Jaenisch and Bird, 2003) . It has been proposed that like in plants, DNA methylation in mammals plays a role in suppression of transposable elements (Yoder et al., 1997) . IAP activation and transposition in vivo observed in hypomethylated mice provide clear evidence for the indispensable role of DNA methylation in maintenance of genome ecology in mammals.
Genomewide DNA hypomethylation is a consistent finding in human tumors, but the importance of this change for human tumorigenesis remains an open question. By analysing a mouse model, we have demonstrated that hypomethylation can result in tumorigenesis and identified two mechanisms that mediate this effect. Hypomethylated cells exhibit inherent chromosomal instability, which can lead to loss of heterozygosity in soft tissue tumors and in intestinal adenomas (Yamada et al., 2005) , and is revealed in hypomethylation-induced lymphomas as a consistent trisomy of chromosome 15 . Although the mechanism is still not clear, accumulating evidence now link hypomethylation of certain repetitive elements to chromosomal instability in human cancer (Wong et al., 2001; Schulz et al., 2002; Tsuda et al., 2002; Ehrlich et al., 2003) . We now find that in addition to reducing chromosomal stability, hypomethylation can promote tumor development in mice by promoting activation and transposition of endogenous retroviral elements. Endogenous transposable elements are not considered important players in human disease, and the relevance of this mechanism to hypomethylation in human tumors remains to be determined.
